Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

POSTINOR 2 TABLET 0.75 mg - HSA Drug Approval Details

Approvals/HSA/POSTINOR 2 TABLET 0.75 mg

Approved

THERAPEUTIC

POSTINOR 2 TABLET 0.75 mg

CHEMICAL WORKS OF GEDEON RICHTER PLC🇸🇬 Health Sciences Authority

Approval Date: Mar 5, 2002
Approval ID: f82b21303b576af3
Company: CHEMICAL WORKS OF GEDEON RICHTER PLC
Type: Therapeutic

Approval Details

Approval Id: f82b21303b576af3
Drug Name: POSTINOR 2 TABLET 0.75 mg
Product Name: POSTINOR 2 TABLET 0.75 mg
Approval Number: SIN11836P
Approval Date: 2002-03-05
Registrant: PHARMLINE MARKETING PTE. LTD.
Licence Holder: PHARMLINE MARKETING PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: TABLET
Route Of Administration: ORAL
Atc Code: G03AD01
Atc Item Name: levonorgestrel
Pharma Manufacturer Name: PHARMLINE MARKETING PTE. LTD.
Company Detail Path: /organization/pharmline-marketing-pte-ltd

Active Ingredients

LEVONORGESTREL

0.75 mg

LEVONORGESTREL

0.75 mg

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Mar 5, 2002

Approval ID

f82b21303b576af3

Type

Therapeutic

Back to HSA Approvals